11/14/2013

The myPath Melanoma test, a 23-gene panel used to diagnose melanoma, has been released by Myriad Genetics. The assay has been shown in a verification study to have a higher than 90% accuracy rate in distinguishing benign skin lesions from malignant melanoma.

Related Summaries